Health Care & Life Sciences » Pharmaceuticals | Polydex Pharmaceuticals Ltd.

Polydex Pharmaceuticals Ltd.

Polydex Pharmaceuticals Ltd.
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$3.72 M
Shares Outstanding
3.38 M
Public Float
-

Profile

Address
421 Comstock Road
Toronto Ontario M1L 2H5
Canada
Employees -
Website http://www.polydex.com
Updated 07/08/2019
Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. If focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals.

Financials

View All

George G. Usher
Chairman, President & Chief Executive Officer
Joseph Buchman
Director